Patents Represented by Attorney Mark K Hehman
  • Patent number: 7585949
    Abstract: The invention is directed to novel, purified and isolated IL-1 zeta and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: September 8, 2009
    Assignee: Immunex Corporation
    Inventors: John E. Sims, Dirk E. Smith, Teresa L. Born